These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 24452673

  • 1. An international phase 3 trial in head and neck cancer: quality of life and symptom results: EORTC 24954 on behalf of the EORTC Head and Neck and the EORTC Radiation Oncology Group.
    Bottomley A, Tridello G, Coens C, Rolland F, Tesselaar ME, Leemans CR, Hupperets P, Licitra L, Vermorken JB, Van Den Weyngaert D, Truc G, Barillot I, Lefebvre JL.
    Cancer; 2014 Feb 01; 120(3):390-8. PubMed ID: 24452673
    [Abstract] [Full Text] [Related]

  • 2. The course of health-related quality of life in head and neck cancer patients treated with chemoradiation: a prospective cohort study.
    Verdonck-de Leeuw IM, Buffart LM, Heymans MW, Rietveld DH, Doornaert P, de Bree R, Buter J, Aaronson NK, Slotman BJ, Leemans CR, Langendijk JA.
    Radiother Oncol; 2014 Mar 01; 110(3):422-8. PubMed ID: 24582144
    [Abstract] [Full Text] [Related]

  • 3. Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.
    Rischin D, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Braña I, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Ishak WZW, Hong RL, Mendoza RG, Jia L, Chirovsky D, Norquist J, Jin F, Burtness B.
    Oral Oncol; 2022 May 01; 128():105815. PubMed ID: 35381576
    [Abstract] [Full Text] [Related]

  • 4. Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab.
    Curran D, Giralt J, Harari PM, Ang KK, Cohen RB, Kies MS, Jassem J, Baselga J, Rowinsky EK, Amellal N, Comte S, Bonner JA.
    J Clin Oncol; 2007 Jun 01; 25(16):2191-7. PubMed ID: 17538164
    [Abstract] [Full Text] [Related]

  • 5. Tumor site and disease stage as predictors of quality of life in head and neck cancer: a prospective study on patients treated with surgery or combined therapy with surgery and radiotherapy or radiochemotherapy.
    Veldhuis D, Probst G, Marek A, Noack V, Ural A, Adamietz I, Dazert S, Minovi A.
    Eur Arch Otorhinolaryngol; 2016 Jan 01; 273(1):215-24. PubMed ID: 25575842
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer.
    Yang CJ, Roh JL, Kim MJ, Lee SW, Kim SB, Choi SH, Nam SY, Kim SY.
    Qual Life Res; 2016 Jan 01; 25(1):165-74. PubMed ID: 26156405
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prospective, longitudinal quality-of-life study of patients with head and neck cancer: a feasibility study including the EORTC QLQ-C30.
    Hammerlid E, Bjordal K, Ahlner-Elmqvist M, Jannert M, Kaasa S, Sullivan M, Westin T.
    Otolaryngol Head Neck Surg; 1997 Jun 01; 116(6 Pt 1):666-73. PubMed ID: 9215381
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG, Tan DS, Tan VK, Wang W, Hwang J, Tan NC, Sivanandan R, Tan HK, Lim WT, Ang MK, Wee J, Soo KC, Tan EH.
    Cancer; 2015 May 15; 121(10):1599-607. PubMed ID: 25639864
    [Abstract] [Full Text] [Related]

  • 18. Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522.
    Truong MT, Zhang Q, Rosenthal DI, List M, Axelrod R, Sherman E, Weber R, Nguyen-Tân PF, El-Naggar A, Konski A, Galvin J, Schwartz D, Trotti A, Silverman C, Singh A, Godette K, Bonner JA, Jones CU, Garden AS, Shenouda G, Matthiesen C, Le QT, Bruner D.
    Int J Radiat Oncol Biol Phys; 2017 Mar 15; 97(4):687-699. PubMed ID: 27727066
    [Abstract] [Full Text] [Related]

  • 19. Influence of pain severity on the quality of life in patients with head and neck cancer before antineoplastic therapy.
    Oliveira KG, von Zeidler SV, Podestá JR, Sena A, Souza ED, Lenzi J, Bissoli NS, Gouvea SA.
    BMC Cancer; 2014 Jan 24; 14():39. PubMed ID: 24460780
    [Abstract] [Full Text] [Related]

  • 20. Head and neck specific Health Related Quality of Life scores predict subsequent survival in successfully treated head and neck cancer patients: a prospective cohort study.
    Osthus AA, Aarstad AK, Olofsson J, Aarstad HJ.
    Oral Oncol; 2011 Oct 24; 47(10):974-9. PubMed ID: 21856209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.